Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to prepare moms for Baby's opioid withdrawal

NCT ID NCT04783558

Knowledge-focused Sponsor: Washington State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is developing and testing a mobile app to teach pregnant women with opioid use disorder how to care for newborns who may experience neonatal abstinence syndrome (NAS). The app provides training on comforting techniques like swaddling, skin-to-skin contact, and feeding. Researchers will test the app with 30 pregnant women to see if it is easy to use and helpful, and measure effects on maternal drug relapse and newborn hospital stays.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mobile-based NAS Caregiving Tool (behavioral intervention)
What this could lead to
If successful, this app could help mothers learn caregiving skills during pregnancy, potentially improving newborn outcomes and reducing hospital stays.
What could go wrong
This is a small early-stage study (30 participants) focused on usability and feasibility, not on proving effectiveness. The app may not change outcomes in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant woman in the third trimester currently in OAT treatment for opioid use disorder * 18 years of age or older * Ability to speak and understand English. Exclusion Criteria: • Recurring (e.g. daily or almost daily) thoughts of harming themselves or others in the past 2 weeks.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neonatal abstinence syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

opiate dependence neonatal abstinence syndrome prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neonatal abstinence syndrome Opioid-use disorder

Contacts and locations

Locations

  • Washington State University

    Spokane, Washington, 99210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.